BackTable / OBGYN / Article
Menopause Hormone Levels: Do Lab Values Inform Therapy?

Sophie Frankenthal • Updated Feb 5, 2025 • 33 hits
Menopause is the biological transition that marks the end of a woman’s reproductive years, typically occurring between the ages of 45 and 55. It is defined by the absence of menstruation for 12 consecutive months and is accompanied by significant hormonal changes. As ovarian function declines, estrogen and progesterone levels gradually decrease, leading to a variety of symptoms such as hot flashes, vaginal dryness, mood changes, sexual dysfunction, and sleep disturbances. Hormone replacement therapy (HRT) is often considered to manage these symptoms and address long-term health risks associated with hormonal decline.
Gynecologist Dr. Jessica Ritch, host of the EnRitched podcast, explains the hormonal changes that occur during menopause as well as their implications for clinical practice. This article features excerpts from the BackTable OBGYN Podcast. We’ve provided the highlight reel in this article, but you can listen to the full podcast below.
The BackTable OBGYN Brief
• Hormone changes in menopause result from declining ovarian function, with progesterone and estrogen levels declining first, followed by a gradual decline in testosterone over several years.
• Routine hormone testing is not necessary for diagnosing menopause and should primarily be used to exclude other conditions. Clinical guidelines recommend a symptom-based approach to menopause management rather than reliance on laboratory values.
• Testosterone therapy may improve energy, libido, and muscle mass, but should be used cautiously due to potential side effects and limited long-term safety data.
• Testosterone supplementation is administered topically at one-tenth of the male dose. Dosage should be adjusted based on individual responses to treatment.

Table of Contents
(1) Postmenopausal Hormone Production
(2) The Role of Hormone Evaluation in Menopause
(3) Testosterone Supplementation in Menopause: Benefits, Risks & Dosage
Postmenopausal Hormone Production
Hormonal changes in menopause are a result of decreased ovarian function. Progesterone is the first hormone to decline due to the cessation of ovulation, followed by estrogen, which declines as the ovaries become less responsive to rising FSH levels. Despite the reduction in estrogen and progesterone, postmenopausal ovaries continue to produce some testosterone, with levels gradually declining over a period of several years. The adrenal glands also contribute to hormone production, but at much lower levels compared to the ovaries.
Perimenopausal symptoms are often driven by fluctuating estrogen levels rather than absolute deficiencies. This underscores the importance of a symptom-based approach to management rather than relying on frequent hormone monitoring.
[Dr. Mark Hoffman]
Do the ovaries still make a physiologic amount of testosterone that's of value after menopause? I know that there was this whole push, I think, like when we were in training, I'm a little bit older than you, but it was, "If you're going to get a hysterectomy, leave the ovaries out." In the last 10 or 15 years or so, I've been like, "Leave them in no matter what, unless there's something wrong with them." Now the pendulum has swung back, saying, "Probably can take them out at 50," or, "If you take them out earlier, you can probably just give them HRT and they're fine."
What do we know about postmenopausal ovaries, what they do, whether it's estrogen, progesterone, testosterone, and how are you counseling patients on that?
[Dr. Jessica Ritch]
Generally the first thing that drops off is the progesterone. That's typically because not really ovulating regularly anymore. If you're not having that ovulation trigger, you're not getting that same rise in progesterone that you usually get after ovulation. That tends to drop off first. I think that's why I have so many patients who come in to see me who are just on progesterone. They've gotten some labs that show that they're low, I don't see much value in that. Progesterone, there's some evidence that it can help with sleep for people with sleep apnea, but in general, nobody should just be on progesterone.
Then, of course, the estrogen starts to drop off as the ovaries aren't responding more to the FSH. Even though FSH is going up and up, the ovaries are going to stop responding at some point so the estrogen is going to drop off as well. Then testosterone is a little bit of a lag. It's a couple of years behind the estrogen and progesterone in terms of the drop-off because it's not really the same cyclic stimulation that we see in the ovaries for the menstrual cycle. The ovaries are still producing some testosterone even when the estrogen and progesterone are dropping. Then of course we have steroid hormone production in the adrenal glands, although much less so than we were getting from the ovaries. It is a little bit of a slow drop.
Like I said, the majority of symptoms that we're seeing in perimenopause and menopause are due to, first of all, the erratic fluctuations of estrogen that are happening in perimenopause. I will have some of those patients that come to me that are monitoring their labs all the time. I have a nurse who I see, and she's always like, "But the estrogen was so high." Then we go through the pattern. We're like, "Yes, it went high because the FSH was so high. Then it stimulated the estrogen." We're not going to treat the numbers. We're going to treat how people feel, stabilize things along the way, and then see what we need to add back in to get you feeling better.
Listen to the Full Podcast
Stay Up To Date
Follow:
Subscribe:
Sign Up:
The Role of Hormone Evaluation in Menopause
Hormone testing is generally unnecessary for diagnosing menopause, and should primarily be used to exclude other conditions such as PCOS, thyroid disease, or hyperprolactinemia. Although follicle-stimulating hormone (FSH) levels can help confirm perimenopause, they do not accurately predict the transition to postmenopause. Routine measurement of estradiol, progesterone, and testosterone levels is not required for initial management but may assist in adjusting treatment when necessary.
In addition to being unnecessary, hormone measurements are often unreliable for clinical decision-making due to their daily fluctuations. ACOG and the North American Menopause Society therefore recommend a symptom-based approach to menopause management rather than reliance on laboratory values. Patients should be advised to avoid commercial hormone clinics that focus solely on laboratory results, as treatment decisions should prioritize clinical symptoms such as hot flashes and vaginal dryness rather than numerical values.
[Dr. Mark Hoffman]
Can we talk about labs for a second? I have so many people coming in of all ages, "I want my hormones checked. I want my hormones checked. I want my hormones checked." There are a lot of different types of practices out there. We have patients who see homeopathic or naturopaths, and there are other names they use. People who are getting their hormones checked on a regular basis and they're getting the pellets and the hormonal implants and those things, can we talk a little bit about the hormones because I think I have a very old-school understanding of vaginal dryness, vaginal estrogen, high flashes, systemic estrogen. Otherwise, I got nothing.
I can stay away from those hormone salesmen, snake oil salesmen who are just trying to get rich off normal things. Am I close? Am I way off in my management? Help me out here, because I feel like I'm doing what I was taught years ago. Has much evolved? Tell me how you approach those types of questions, those types of patients
.
[Dr. Jessica Ritch]
Yes, you're actually not that far off. I do-- [chuckles] Give yourself a little pat on the back. The same thing. Many people come in, "I want to check my hormones." At the same time, I don't just say, "Okay, let's check your hormones." I say, "Okay, well, what is it that's bothering you? Why do you want to check your hormones? Let's talk about whether this is going to be useful or not." Most of the time I'm telling them, "I don't think this is going to be very useful, but we can check." Now, sometimes it is, if they're having irregular periods and symptoms, we want to look for things like PCOS. We want to rule out thyroid disease. We want to look for prolactin issues. All of these other things.
Honestly, I'll check an FSH because if it's elevated, it confirms what I tell patients, "We already know that you're at least in perimenopause. The level is not going to tell me when you're postmenopausal. If you don't have a uterus, that's a little trickier to do." We have to go by the periods at least somewhat. We'll check an FSH and we'll look at things like estradiol and progesterone and testosterone. I don't even require a baseline for that. I do it if somebody wants to know it, but I'm not going to treat somebody based on those numbers. I would use those numbers more when we're treating somebody, if we want to adjust the dosing or if we want to look and see if things are getting a little too high around those areas, then I would look at those hormones. Most of the time, the labs are fairly useless to me other than ruling out the other conditions that can mimic perimenopause and menopause, particularly thyroid disease.
The way that I always counsel my patients is I tell them, "Look, we're not going to treat a number." While there are, especially here in South Florida, so many of these bioidentical hormone clinics that say, "We're going to test your saliva, your blood, or your urine. We're going to look at these levels of hormones and we're going to give you this number of hormones based on what it is." I have so many patients that come to me and they say, "Well, I'm on this because my level was low." I was like, "Okay, but what were you feeling to get on this?" I don't want to treat a number. I don't want to treat a lab. What number you have today is going to be different than the number you have tomorrow versus next week because they're still fluctuating. What number feels good to me is going to be different than what number feels good to my patient and to their sister and to their neighbor. We really want to treat based on symptoms, not based on those lab numbers.
[Dr. Mark Hoffman]
Okay, good. I feel a little bit better because that's what I tell folks, like, "I care about you and how you feel, not the lab." The lab says you're not in menopause, but you're having hot flashes and vaginal dryness. Do we treat? Do we ignore those symptoms? I don't want to ignore the symptoms if patients are saying they're having those symptoms.
[Dr. Jessica Ritch]
You're in line with ACOG and the North American Menopause Society, so don't worry, you're on the right track.
Testosterone Supplementation in Menopause: Benefits, Risks & Dosage
Testosterone production declines later in menopause compared to estrogen and progesterone, but its role in symptom management is evolving. Supplementation has been shown to improve energy, libido, and muscle mass; however, potential side effects such as acne, hirsutism, and virilization must be carefully considered. Data on the long-term risks of testosterone therapy in women are limited, with most studies being short-term or involving formulations not widely available in the United States.
Testosterone supplementation should be considered a secondary option for patients with persistent symptoms despite estrogen therapy. It is typically administered topically at approximately one-tenth of the male dose. Regular monitoring aims to prevent excessively high levels rather than achieve a specific therapeutic target, as optimal ranges for women have not been well established. Dosage adjustments should be guided by symptom response and side effect tolerance, ensuring individualized treatment.
[Dr. Mark Hoffman]
Good. The other big thing I want to ask, though, about this in terms of hormones is testosterone. A lot of testosterone questions, and I feel like I don't know anything helpful to tell patients about testosterone. I know that ovaries do produce testosterone, and I understand that when you go into menopause, your ovarian hormone production goes down. That includes testosterone. You're nodding, so I'm hoping that I'm somewhat right here. Tell me what you know about testosterone in the menopausal patient and what we can be telling our patients.
[Dr. Jessica Ritch]
That is true. Definitely, the ovaries are producing testosterone. The testosterone seems to drop off a little bit later than the estrogen does. We tend to lose estrogen a little bit sooner and progesterone. The testosterone drops off a little bit later. I will tell you that my opinion on testosterone has been evolving, and it's still evolving, but here's what we know.
We do know that women who are getting testosterone supplementation do feel better in terms of less fatigue, more energy. They have improvements in libido and muscle mass, so it can be helpful in those ways. We do know there can be side effects to testosterone, so abnormal hair growth, acne, virilization things like voice deepening, clitoromegaly, things like that, that people don't necessarily want.
We don't know a whole lot about risks. These are not really well studied in women. The studies that we do have typically are followed for six months or less. They're usually using a topical patch that's not available in the United States. It looks like, at least from those small studies, that things are fairly safe in women. When we look at men, of course, the concerns in men are always things like cancers; prostate and testicular cancers, and cardiovascular disease. Some of the newer evidence suggests that it may be safer in men than we had originally thought, but there's really still not a lot of data on women.
It's not something that I start with. The argument I think a lot of people make who do a lot of testosterone therapy is that we would offer this to men. We care more about men's quality of life, it seems, than we care about women's. I agree, there are a lot of things that we do for men that we don't necessarily do for women, but I do think it's more of a conversation. I do think it shouldn't be a, "Well, your testosterone is low and you need testosterone." It should be a conversation about the risks and benefits. Just because somebody's male partner will take anything at any risk to improve their sex life, does not necessarily mean that the woman wants to do the same. It's really a conversation about risks and benefits.
When I'm starting someone on a hormone replacement therapy, I always start with estrogen, and then, of course, progesterone, if they have a uterus, to protect the uterus. Then even if they've come to me for testosterone, I say, "Well, let's just wait on that. Let's see how you feel first with the estrogen," because a lot of the symptoms that they're having in terms of the fatigue and also the libido and energy, those are going to improve with the estrogen alone, which are much better studied. We know the risks and benefits in women of estrogen and progesterone much better than we know testosterone. Then I say, "If you're still having very bothersome symptoms, then we're going to consider adding a topical testosterone," but that can get a little bit trickier.
[Dr. Mark Hoffman]
Is it trial and error, really? Are you measuring testosterone? I know we talked about labs a minute ago, but do you check testosterone levels in women at all? Is there any value in that?
[Dr. Jessica Ritch]
I do check them initially, but again, the initial is really more to rule out the other things, particularly in the perimenopausal person, to see if it's a PCOS issue or something along those lines. If I'm supplementing testosterone, which again, I don't start with, so it's not the majority of my patients who are on testosterone, but if I'm supplementing testosterone, then I will check the levels mostly to make sure that they're not getting crazy high. There are no set therapeutic levels for what a woman's testosterone should be, so it's not like you're titrating a dose to a specific level. It's more like, "Okay, well, what's the normal range of what a woman should have?"
I do have some patients who are on the pellets and other things, not that I've given them the pellets because I do not do that, but who have come in on pellets. Sometimes their levels are three, four times what a normal female should have in terms of a testosterone level. I don't think that's where anybody needs to be.
[Dr. Mark Hoffman]
What are the kinds of things we should be looking for? You mentioned energy and libido. In terms of response and dosing and things like that, we don't need to go through specific doses, but is it similar to estrogen where it's like, "Let's give you a little more, see how you feel. Let's give you a little more, see how you feel." Then you have a point where "Okay, I don't think any more is going to help," and it's more of a trial-and-error type thing?
[Dr. Jessica Ritch]
A little bit. There are some guidelines. There are basically a couple of different ways that you can do testosterone. Some people will do injections in the pellets. Like you said, I don't do that. The pellets I'm not really that comfortable with. I think they're poorly regulated, not well studied, can be inconsistent. There is, of course, FDA-approved testosterone for men. Topical, a gel product that you can use. Generally, for women, we just start at a 10th of the dose of men. Not super scientific. It's like a pea-sized amount that they rub into their skin. That's one way to do it. They probably won't have that covered by their insurance, but because the tube is going to last them so much longer than it would for a man, it's usually one or two tubes in a year.
The other way is to use a compounding pharmacy, which as I said, I'm not a huge fan of compounded bioidentical hormones. I do use compounding pharmacies when I need to, when I can't get something that's commercially available. I have a few in my area that I feel comfortable with, but it's sort of the same thing. We just start at a low dose and then we build up from there. I will talk with the pharmacist specifically about how they make that and how we can dose each patient.
Really then, I'm checking the levels to see, "Okay, are we getting too high?" Then for the effectiveness to see, basically it's always, "How do you feel? How do you feel with that?" Some people feel great with it. I would say the majority feel great. They have more energy. They have their sex lives back, but I do have a lot of people too who are just like, "Whoa, that was too much. I don't want to be on that anymore." It's always trial and error. You have to see how each person is going to respond to it, just like with anything else.
Podcast Contributors
Dr. Jessica Ritch
Dr. Jessica Ritch is a minimally invasive gynecologist at Florida Center for Urogynecology in Miami.
Dr. Mark Hoffman
Dr. Mark Hoffman is a minimally invasive gynecologic surgeon at the University of Kentucky.
Cite This Podcast
BackTable, LLC (Producer). (2024, April 16). Ep. 51 – Menopause Matters: Clinical Strategies & Patient Support [Audio podcast]. Retrieved from https://www.backtable.com
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.